Skip to main content
Premium Trial:

Request an Annual Quote

Signal Genetics Lab Nabs CAP Accreditation

NEW YORK (GenomeWeb) – Signal Genetics today announced that the College of American Pathologists has awarded accreditations to the firm's Little Rock, Ark.-based laboratory.

"This further demonstrates our company's dedication to providing a quality diagnostic to patients suffering from multiple myeloma, and the physicians who treat them, in order to improve individual care," Signal CEO Sam Riccitelli said in a statement.

Carlsbad, Calif.-based Signal Genetics provides oncology molecular diagnostic services, offering the MyPRS microarray gene expression profiling assay for multiple myeloma. In February, the firm closed a $9 million public offering.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more